双水平正压通气治疗顽固性心力衰竭所致低氧血症23例  

Therapeutic observation of Bi-level positive airway pressure ventilation in treating hypoxemia in-duced by refractory heart failure

作　　者：何晃养 张文勇 陈辉 

机构地区：[1]广东省新兴县人民医院急诊科何晃养,ICU,呼吸内科527400

出　　处：《中国实用医刊》2012年第6期53-55,共3页Chinese Journal of Practical Medicine

摘　　要：目的观察双水平气道正压通气（BiPAP）呼吸机面／鼻罩正压通气治疗顽固性心力衰竭所致低氧血症的临床疗效。方法将48例顽固性心力衰竭所致低氧血症的患者采用完全随机设计方法，分为试验组23例和对照组25例，对照组采用常规治疗，试验组在常规治疗的基础上加用BiPAP呼吸机面／鼻罩正压通气治疗，所有患者分别在治疗前及治疗24h后测定pH值、动脉血氧分压及动脉血二氧化碳分压，并记录临床症状的变化。结果24h后临床症状和各指标的改善情况试验组明显好于对照组。结论BiPAP是治疗顽固性心力衰竭所致低氧血症的一种较好的无创通气模式。Objective To observe the clinical effect of bi-level positive airway pressure ven- tilation（BiPAP） repiratory therapy on hypoxemia due to refractory heart failure. Methods Forfty- eight patients with hypoxemia due to refractory heart failure were divided into control group （ n = 23） and treatment group （ n = 25 ）. The control group was treated with common therapy and the treatment group was treated with both common therapy and BiPAP. pH, PaO2 and PaCO2 were ana- lyzed before and 24 h after therapy, meanwhile changes of clinical symptoms were recorded. Results Symptoms of the treatment group showed more improvement than the control group 24 h after thera- py. Conclusions BiPAP is an optimistic and non traumatic method for treating hypoxemia due to refractory heart failure.

关 键 词：双水平气道正压通气 顽固性心力衰竭 低氧血症 

分 类 号：R541.6[医药卫生—心血管疾病]